Menu
Back to User profile » Drs Yuemin Nan
Papers published by Drs Yuemin Nan:
The Potential of the lncRNAs ADAMTSL4-AS1, AC067931 and SOCS2-AS1 in Peripheral Blood Mononuclear Cells as Novel Diagnostic Biomarkers for Hepatitis B Virus-Associated Hepatocellular Carcinoma
Guan W, Zhang C, Miao T, Dong C, Li L, Yuan X, Zhao D, Ai R, Zhang X, Sun M, Kang H, Nan Y
Journal of Hepatocellular Carcinoma 2024, 11:1221-1233
Published Date: 27 June 2024
Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio Predicts Prognosis of Hepatocellular Carcinoma in Patients with Metabolic-Associated Fatty Liver Disease
Miao T, Lou X, Dong S, Zhang X, Guan W, Zhang Y, Li L, Yuan X, Ma D, Nan Y
Journal of Hepatocellular Carcinoma 2024, 11:145-157
Published Date: 18 January 2024
LINC00886 Facilitates Hepatocellular Carcinoma Tumorigenesis by Sequestering microRNA-409-3p and microRNA-214-5p
Li L, Ai R, Yuan X, Dong S, Zhao D, Sun X, Miao T, Guan W, Guo P, Yu S, Nan Y
Journal of Hepatocellular Carcinoma 2023, 10:863-881
Published Date: 8 June 2023
Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology
Zhao D, Zhang X, Tang Y, Guo P, Ai R, Hou M, Wang Y, Yuan X, Cui L, Zhang Y, Zhao S, Li W, Wang Y, Sun X, Liu L, Dong S, Li L, Zhao W, Nan Y
Journal of Hepatocellular Carcinoma 2022, 9:389-403
Published Date: 9 May 2022
ADAMTS8 targets ERK to suppress cell proliferation, invasion, and metastasis of hepatocellular carcinoma
Zhao XT, Yang CR, Wu JH, Nan YM
OncoTargets and Therapy 2018, 11:7569-7578
Published Date: 29 October 2018